Zdrowie i gospodarka · 25/10/2007

FDA Issues Notice for Direct-to-Consumer Television Advertisements User Fee Program for Prescription Drugs and Biological Products

The Food and Drug Administration (FDA) is issuing a notice to explain a new user fee program for reviewing direct-to-consumer television advertisements for prescription drugs and biological products. Companies must notify the FDA within 30 days if they plan to participate in the program during fiscal year 2008 and identify the number of advertisements they plan to submit for review.